vitronectin antagonists (Shire)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namevitronectin antagonists (Shire)
Drug Alias Namealpha-v/beta-3 antagonists (Shire)alpha-v/beta-5 antagonists (Shire)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsAngiogenesis disorderBone Diseases, MetabolicNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShire
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderBone Diseases, MetabolicNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A